𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Weekly adriamycin® vs. 4-epidoxorubicin every second week in advanced breast cancer. A randomized trial

✍ Scribed by Gundersen, S.; Kvinnsland, S.; Klepp, O.; Lund, E.; Høst, H.


Book ID
122815548
Publisher
Elsevier Science
Year
1990
Weight
409 KB
Volume
26
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES